Full-Time
Healthcare consultancy translating science into branding
No salary listed
England, UK
In Person
BGB Group is a healthcare consultancy that turns scientific advances into strategic brand stories. It offers medical communications, market access, and payer strategy services to pharmaceutical, biotech, and medical device clients. The company works by applying a blend of clinical, academic, and industry expertise to translate research findings into clear messaging and practical market strategies, delivered through project-based engagements. Unlike firms that focus on a single discipline, BGB Group combines scientific depth with creative storytelling to deliver real-world impact for clients, including streamlined access to payers and clearer communication of value. Its goal is to help clients translate transformative science into tangible outcomes, accelerating adoption, reimbursement, and patient access through targeted communications and market strategies.
Company Size
501-1,000
Company Stage
N/A
Total Funding
N/A
Headquarters
New York City, New York
Founded
2014
Help us improve and share your feedback! Did you find this helpful?
People at BGB Group who can refer or advise you
Hybrid Work Options
Professional Development Budget
BGB Group, a commercial solutions company for biopharmaceutical firms, has acquired Hayden Consulting Group, a market access and patient services consultancy. Financial terms were not disclosed. Hayden specialises in resolving complex payer, reimbursement and affordability challenges for global pharmaceutical brands. The acquisition combines Hayden's market access expertise with BGB's strategic advisory services, which span commercial due diligence, new product planning and go-to-market strategies. Hayden will continue to be led by co-founders Jamie Sidore and David MacDougall, becoming part of BGB's strategic advisory practice headed by Hilary Gentile. The combined entity aims to provide clients with integrated solutions across the full brand lifecycle, from early planning through commercialisation.
BGB Group appoints David Coman as Chief Executive Officer.
BGB Group recently hired Chris Palmer as its new chief creative officer, who joined from Havas Life New York.
Kuzel comes to imre from BGB Group, where she was EVP data, analytics and customer experience.
NEW YORK--(BUSINESS WIRE)--BGB Group (BGB), an award-winning healthcare commercialization and communications company headquartered in New York City with offices in Washington DC, Boston, and London, today announced a strategic partnership with Scrum50 (S50), a dynamic, agile-first creative agency based in South Norwalk, CT. This collaboration marks a transformative alliance, the next phase of BGB’s expertise enhancement aimed at remaining ahead of biopharma’s biggest challenges. The teams are set to redefine creativity and impact in the healthcare sector. S50 will continue to operate independently across all industry sectors. “We are excited to formalize our partnership with S50,” noted Greg Passaretti, Founding Partner of BGB Group. “We’ve been working together for nearly a year, and we realized that there’s much more that we can accomplish for a marketplace in need of broader creative and engagement solutions.”